These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15002407)

  • 1. Alpha-thujone reduces 5-HT3 receptor activity by an effect on the agonist-reduced desensitization.
    Deiml T; Haseneder R; Zieglgänsberger W; Rammes G; Eisensamer B; Rupprecht R; Hapfelmeier G
    Neuropharmacology; 2004 Feb; 46(2):192-201. PubMed ID: 15002407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor.
    Hapfelmeier G; Tredt C; Haseneder R; Zieglgänsberger W; Eisensamer B; Rupprecht R; Rammes G
    Biophys J; 2003 Mar; 84(3):1720-33. PubMed ID: 12609874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and electrophysiological properties of the naturally occurring Pro391Arg variant of the human 5-HT3A receptor.
    Kurzwelly D; Barann M; Kostanian A; Combrink S; Bönisch H; Göthert M; Brüss M
    Pharmacogenetics; 2004 Mar; 14(3):165-72. PubMed ID: 15167704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mechanism of modulation at a ligand-gated ion channel; action of 5-Cl-indole at the 5-HT
    Powell AD; Grafton G; Roberts A; Larkin S; O'Neill N; Palandri J; Otvos R; Cooper AJ; Ulens C; Barnes NM
    Br J Pharmacol; 2016 Dec; 173(24):3467-3479. PubMed ID: 27677804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of sodium substitutes on 5-HT-mediated effects at mouse 5-HT3 receptors.
    Barann M; Schmidt K; Göthert M; Urban BW; Bönisch H
    Br J Pharmacol; 2004 Jun; 142(3):501-8. PubMed ID: 15148263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning, functional expression, and pharmacological characterization of 5-hydroxytryptamine3 receptor cDNA and its splice variants from guinea pig.
    Lankiewicz S; Lobitz N; Wetzel CH; Rupprecht R; Gisselmann G; Hatt H
    Mol Pharmacol; 1998 Feb; 53(2):202-12. PubMed ID: 9463477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological consequences of ligand binding to the desensitized 5-HT3 receptor in mammalian NG108-15 cells.
    Bartrup JT; Newberry NR
    J Physiol; 1996 Feb; 490 ( Pt 3)(Pt 3):679-90. PubMed ID: 8683467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of distinct conformational states of the 5-HT3 receptor by full and partial agonists.
    van Hooft JA; Vijverberg HP
    Br J Pharmacol; 1996 Mar; 117(5):839-46. PubMed ID: 8851499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C and E subunits of the serotonin 5-HT
    Yaakob NS; Nguyen DT; Exintaris B; Irving HR
    Biomed Pharmacother; 2018 Jan; 97():1701-1709. PubMed ID: 29793334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 4'lysine in the putative channel lining domain affects desensitization but not the single-channel conductance of recombinant homomeric 5-HT3A receptors.
    Gunthorpe MJ; Peters JA; Gill CH; Lambert JJ; Lummis SC
    J Physiol; 2000 Jan; 522 Pt 2(Pt 2):187-98. PubMed ID: 10639097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of aspartate 298 in mouse 5-HT3A receptor gating and modulation by extracellular Ca2+.
    Hu XQ; Lovinger DM
    J Physiol; 2005 Oct; 568(Pt 2):381-96. PubMed ID: 16096341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of 5-HT3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission.
    Riga MS; Sánchez C; Celada P; Artigas F
    Neuropharmacology; 2016 Sep; 108():73-81. PubMed ID: 27106166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of recognition loops B and D in the activation of human 5-HT₃ receptors by 5-HT and meta-chlorophenylbiguanide.
    Michaelson SD; Paulsen IM; Kozuska JL; Martin IL; Dunn SM
    Neuropharmacology; 2013 Oct; 73():398-403. PubMed ID: 23810831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of domains influencing assembly and ion channel properties in alpha 7 nicotinic receptor and 5-HT3 receptor subunit chimaeras.
    Gee VJ; Kracun S; Cooper ST; Gibb AJ; Millar NS
    Br J Pharmacol; 2007 Oct; 152(4):501-12. PubMed ID: 17721553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central α- and β-thujone: similar anxiogenic-like effects and differential modulation on GABAA receptors in neonatal chicks.
    Rivera EM; Cid MP; Zunino P; Baiardi G; Salvatierra NA
    Brain Res; 2014 Mar; 1555():28-35. PubMed ID: 24486357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric activation of the 5-HT3AB receptor by mCPBG.
    Miles TF; Lester HA; Dougherty DA
    Neuropharmacology; 2015 Apr; 91():103-8. PubMed ID: 25541413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different efficacy of specific agonists at 5-HT3 receptor splice variants: the role of the extra six amino acid segment.
    Niemeyer MI; Lummis SC
    Br J Pharmacol; 1998 Feb; 123(4):661-6. PubMed ID: 9517385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General anesthetic-induced channel gating enhancement of 5-hydroxytryptamine type 3 receptors depends on receptor subunit composition.
    Solt K; Stevens RJ; Davies PA; Raines DE
    J Pharmacol Exp Ther; 2005 Nov; 315(2):771-6. PubMed ID: 16081679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of 5-HT3 receptor function by the activation of coexistent 5-HT2 receptors in trigeminal ganglion neurons of rats.
    Hu WP; Guan BC; Ru LQ; Chen JG; Li ZW
    Neuropharmacology; 2004 Nov; 47(6):833-40. PubMed ID: 15527817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes.
    Oz M; Zhang L; Morales M
    Synapse; 2002 Dec; 46(3):150-6. PubMed ID: 12325042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.